ZNF808 inhibitors refer to a class of chemical compounds that selectively inhibit the activity of the ZNF808 protein, a zinc finger protein involved in transcriptional regulation. ZNF808, like other zinc finger proteins, contains zinc ion-binding motifs that enable it to interact with specific DNA sequences and influence the transcription of target genes. These proteins are critical regulators in gene expression networks, participating in processes such as DNA repair, replication, and chromatin remodeling. By inhibiting ZNF808, these compounds can modulate the activity of the protein, leading to alterations in the transcriptional profiles of genes under its control. This regulation can have broad implications for understanding the pathways and molecular mechanisms associated with ZNF808's regulatory functions.
Inhibitors of ZNF808 may act by disrupting its ability to bind DNA or by interfering with its structural conformation, potentially by targeting the zinc finger motifs or other regions critical for its activity. The specific binding affinities and structural properties of these inhibitors can influence the efficacy and selectivity with which they modulate ZNF808 activity. By studying these interactions, researchers can gain deeper insights into the structural requirements for ZNF808 function and how this protein participates in broader genomic regulatory networks. ZNF808 inhibitors can also serve as valuable molecular tools in biochemical and structural biology research, providing a means to dissect the protein's roles in various cellular processes and its involvement in maintaining the integrity of transcriptional programs.
SEE ALSO...
Items 11 to 14 of 14 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can decrease the expression of ZNF808 by disrupting cellular redox states, which are critical for the maintenance of normal transcriptional activities at the ZNF808 promoter. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib disrupts proteasomal degradation pathways, leading to an accumulation of ubiquitinated proteins, which includes transcription factors that could otherwise enhance ZNF808 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin reduces the transcriptional activity of certain transcription factors at the ZNF808 promoter, leading to decreased expression of the gene. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Through activation of sirtuins, Resveratrol promotes deacetylation of histones associated with the ZNF808 gene, thus reducing transcriptional activity and protein expression. | ||||||